Eight young UCLA professors are among118 scientists and scholars selected today to receive 2022 Sloan Research Fellowships, making UCLA No. 1 among U.S. and Canadian colleges and universities in the number of new fellows
Eight young UCLA professors are among118 scientists and scholars selected today to receive 2022 Sloan Research Fellowships, making UCLA No. 1 among U.S. and Canadian colleges and universities in the number of new fellows
[92 Pages Report] Apoptosis Assay Reagent Market Insights 2022 This report contains market size and forecasts of Apoptosis Assay Reagent in China, including the following market information: China Apoptosis Assay Reagent Market Revenue, 2016-2021, 2022-2027, ($ millions) China Apoptosis Assay Reagent Market Sales, 2016-2021, 2022-2027, (K Units) China top five Apoptosis Assay Reagent companies in 2020 (%) The global Apoptosis Assay Reagent market size is expected to growth from USD million in 2020 to USD million by 2027; it is expected to grow at a CAGR of % during 2021-2027. The China Apoptosis Assay Reagent market was valued at USD million in 2020 and is projected to reach USD million by 2027, at a CAGR of % during the forecast period
This collaboration will also provide an opening to two Emirati research fellows to join the Douglas Melton Lab. Published: Tue 8 Feb 2022, 11:08 AM The Abu Dhabi Crown Prince has announced a financial grant towards the Douglas Melton Laboratory at the Harvard Stem Cell Institute.
Technological developments of the 3D Bioprinters and increasing investment in R & D of stem cell and regenerative medicines are driving the demand of the market. Market Size USD 641.2 million in 2019, Market Growth CAGR of 20.7%, Market Trends The rising prevalence of COVID-19 The global3D Bioprinting Marketis expected to reach USD 2,687.8 million by 2027, according to a new report by Emergen Research.
Pawan Kumar A paper published this week and authored by Pawan Kumar, an assistant professor in the Department of Microbiology and Immunology in Stony Brook Universitys Renaissance School of Medicine, lays the groundwork to better understand and treat Crohns disease, a type of Inflammatory Bowel Disease (IBD). The paper was published inImmunity, a leading research journal from Cell Press that highlights discoveries in immunology. Led by Kumar, the papers senior author, the research identified a new role for Interleukin-17A (IL-17A), an immune cell-derived cytokine, in promoting selective epithelial cell development as well as limiting inflammation during colitis.
At Kings College London, PhD student Dr Loder is looking into the future ethical issues with induced stem cell research. She explains induced stem cells to be reprogramming cells that have already differentiated to become more juvenile, and it is effectively a way to get stem cells without destroying embryos. Induced stem cells can be made from many types of cells, for example skin cells.
Barcelona, 9, February, 2022 The EBMT and EHA are proud to announce the release of the first-ever open-access book on CAR-T cells to be officially launched during the EBMT-EHA 4th European CAR-T Cell Meeting (Feb 10-12, 2022, Virtual). The EBMT/EHA CAR-T Cell Handbook, published by Springer, covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers knowledge and practical skills, provides an expansive overview of the CAR-T cell technology and its application in clinical care.
A Korean research team proposed a detailed classification method based on cancer stem cell RNA characteristics and customized, targeted therapy for intractable hepatocellular carcinoma (HCC) that does not respond to existing treatments. The research team, led by professor Lee Sung-hwan at the Department of Surgery of CHA Bundang Medical Center, published the study in the latest issue of Cancer Communications. The University of Texas MD Anderson Cancer Center in Houston, the U.S., jointly conducted the study
The epithelial cell culture media market is expected to reach US$ 303,040.33 thousand by 2028 from US$ 128,155.95 thousand in 2020; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028. According to our new research study on Epithelial Cell Culture Media Market Forecast to 2028 COVID-19 Impact and Global Analysis by Product Type and End User. The report highlights trends prevailing in the market and factors driving its growth
The report provides an in-depth analysis of the Global Market of Stem Cell Cartilage Regeneration.
Recent Comments